Portfolio trimming by generics manufacturers linked to soaring drug costs

Dwindling pools of manufacturers for some generic drugs are driving up prices, The New York Times reports. The paper focuses on the example of digoxin, a heart drug first described in the medical literature in 1785 that now sells for $1.60 a pill. Until recently the drug sold for far less, but the exit of manufacturers has led to decreased competition and rising costs. Article (sub. req.)

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.